August 14, 2025

Greater Variety of Flavonoids Tied to Lower Chronic Disease

Higher diversity and quantity of dietary flavonoid intake were each linked to reduced risks of mortality and major chronic diseases in a large population-based study.

Conexiant

August 11, 2025

FDA OKs Bioequivalent Iron Sucrose for CKD Anemia

The FDA has approved a bioequivalent iron sucrose injection for treating iron deficiency anemia in patients with chronic kidney disease.

Conexiant

August 07, 2025

Every 1,000 Steps May Slash Heart Risk 17%

Each additional 1,000 daily steps a day may be associated with a reduction in major adverse cardiovascular events among patients with hypertension, with benefits evident at step counts well below 10,000 steps per day.

Conexiant

August 07, 2025

Delayed Hypertension Diagnoses Raise 5-Year Cardiovascular Risk

Analysis of electronic health records reveals that delays in clinical hypertension diagnosis persist despite frequent outpatient visits and are linked to increased cardiovascular event rates.

Conexiant

August 07, 2025

Study Ties Asthma to Cardiometabolic Risk

Researchers studying nearly 29,000 middle-aged adults in Sweden found that individuals with asthma had significantly higher rates of hypertension, diabetes, and other conditions, along with elevated levels of systemic inflammation and blood sugar markers.

Conexiant

August 06, 2025

New COVID Booster Matches Efficacy, Raises Antibodies

A phase 3 randomized trial found that Moderna’s next-generation COVID-19 vaccine, mRNA-1283, was non-inferior to the earlier mRNA-1273 vaccine in preventing COVID-19 and produced stronger neutralizing antibody responses.

Conexiant

August 06, 2025

Do Retail Health Kiosks Tell Different Story?

Analysis of U.S. retail health kiosk users reveals that nearly half had high blood pressure, with the highest prevalence among non-Hispanic Black adults.

Conexiant

August 05, 2025

Periodontal Disease: Systemic Associations Across Multiple Organ Systems

Evidence links periodontal inflammation to systemic dysfunction across cardiovascular, endocrine, renal, respiratory, and neurologic systems.

Conexiant

August 05, 2025

Weight Regain Persists After Anti-Obesity Treatment

A new meta-analysis of 11 randomized controlled trials found that patients began regaining weight as early as 8 weeks after discontinuing anti-obesity medications, with weight gain continuing through 52 weeks.

Conexiant